- Home
- ALXO vs PVL Comparison
ALXO vs PVL Comparison
Compare ALXO & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALXO | PVL |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.3M | 57.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALXO | PVL |
|---|---|---|
| Price | $2.08 | $1.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.42 | N/A |
| AVG Volume (30 Days) | ★ 998.4K | 86.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.46% |
| EPS Growth | ★ 31.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $1.30 |
| 52 Week High | $2.66 | $2.04 |
Technical Indicators
Market Signals| Indicator | ALXO | PVL |
|---|---|---|
| Relative Strength Index (RSI) | 49.66 | 42.83 |
| Support Level | $1.41 | $1.40 |
| Resistance Level | $2.27 | $1.88 |
| Average True Range (ATR) | 0.26 | 0.05 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 10.77 | 43.75 |
Price Performance
Historical ComparisonAbout ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.